|Bid||17.00 x 800|
|Ask||20.33 x 800|
|Day's Range||19.14 - 19.55|
|52 Week Range||16.91 - 21.63|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||374.04|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.
7 Million for the Three Months Ended June 30, 2021RANCHO CUCAMONGA, CA / ACCESSWIRE / August 9, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2021.
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2021 ended June 30, 2021, after the market closes on Monday, August 9th, 2021, and will hold a conference call to discuss its financial results at 2:00 p.